These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 17662089)

  • 21. Factors associated with preventability, predictability, and severity of adverse drug reactions.
    Gholami K; Shalviri G
    Ann Pharmacother; 1999 Feb; 33(2):236-40. PubMed ID: 10084421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reactions in hospital in-patients: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2006 Aug; 31(4):335-41. PubMed ID: 16882102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a university hospital in New Delhi.
    Alam MS; Pillai KK; Abdi SAH; Kapur P; Pillai PK; Nagarajan K
    Korean J Intern Med; 2018 Nov; 33(6):1203-1209. PubMed ID: 28874042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.
    Modayil RR; Harugeri A; Parthasarathi G; Ramesh M; Prasad R; Naik V; Giriyapura V
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):247-55. PubMed ID: 20066675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals.
    Harugeri A; Parthasarathi G; Ramesh M; Guido S; Basavanagowdappa H
    J Postgrad Med; 2011; 57(3):189-95. PubMed ID: 21941055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of adverse drug reactions to radiographic contrast media reported during a 3 year period in a tertiary care hospital in south India.
    Subathra A; Sandhiya S; Kesavan R
    Indian J Physiol Pharmacol; 2014; 58(1):45-50. PubMed ID: 25464676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study.
    Sharma M; Baghel R; Thakur S; Adwal S
    BMJ Open; 2021 Oct; 11(10):e052737. PubMed ID: 34607871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of adverse drug reactions in adult medical inpatients.
    Bowman L; Carlstedt BC; Black CD
    Can J Hosp Pharm; 1994 Oct; 47(5):209-16. PubMed ID: 10172139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?
    Lau PM; Stewart K; Dooley M
    Support Care Cancer; 2004 Sep; 12(9):626-33. PubMed ID: 15064936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
    Betancourt BY; Marrero-Miragaya MA; Jiménez-López G; Valenzuela-Silva C; García-Iglesias E; Hernández-Bernal F; Debesa-García F; González-López T; Alvarez-Falcón L; López-Saura PA;
    BMC Clin Pharmacol; 2005 Nov; 5():5. PubMed ID: 16262910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous Adverse Drug Reaction Monitoring in a Tertiary Care Centre.
    Kaur K; Kanwal P; Goyal P; Singh P; Yakhmi S; Jain S; Kaushal S
    Curr Drug Saf; 2020; 15(3):215-221. PubMed ID: 32735525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
    Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
    BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse drug reactions experience in a teaching hospital in Jordan.
    Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
    Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.